Loomis Sayles & Co. L P trimmed its position in Limbach Holdings, Inc. (NASDAQ:LMB – Free Report) by 4.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 138,199 shares of the construction company’s stock after selling 5,938 shares during the quarter. Loomis Sayles & Co. L P’s holdings in Limbach were worth $10,470,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently modified their holdings of the company. Charles Schwab Investment Management Inc. increased its holdings in Limbach by 186.1% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 83,945 shares of the construction company’s stock worth $6,360,000 after buying an additional 54,599 shares during the period. Segall Bryant & Hamill LLC lifted its stake in Limbach by 37.1% during the 3rd quarter. Segall Bryant & Hamill LLC now owns 103,008 shares of the construction company’s stock valued at $7,804,000 after acquiring an additional 27,855 shares during the period. Quest Partners LLC purchased a new stake in shares of Limbach in the 3rd quarter valued at $207,000. Thrivent Financial for Lutherans increased its stake in shares of Limbach by 0.8% in the third quarter. Thrivent Financial for Lutherans now owns 46,987 shares of the construction company’s stock worth $3,560,000 after acquiring an additional 382 shares during the period. Finally, Empowered Funds LLC raised its holdings in shares of Limbach by 4.9% during the third quarter. Empowered Funds LLC now owns 8,618 shares of the construction company’s stock worth $653,000 after purchasing an additional 402 shares during the last quarter. Institutional investors and hedge funds own 55.85% of the company’s stock.
Limbach Stock Performance
Shares of NASDAQ LMB opened at $98.76 on Thursday. Limbach Holdings, Inc. has a 1 year low of $35.24 and a 1 year high of $104.98. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.57 and a current ratio of 1.57. The company’s fifty day moving average price is $83.52 and its 200 day moving average price is $67.80. The company has a market capitalization of $1.11 billion, a PE ratio of 44.89, a price-to-earnings-growth ratio of 3.37 and a beta of 0.97.
Insider Activity
In other news, Director Joshua Horowitz sold 7,000 shares of Limbach stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $61.86, for a total value of $433,020.00. Following the sale, the director now owns 203,000 shares in the company, valued at $12,557,580. This trade represents a 3.33 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 10.20% of the company’s stock.
Analyst Ratings Changes
LMB has been the topic of several recent research reports. Stifel Nicolaus started coverage on Limbach in a research report on Friday, November 15th. They set a “buy” rating and a $108.00 price target on the stock. Roth Mkm raised their target price on Limbach from $67.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Finally, StockNews.com downgraded Limbach from a “buy” rating to a “hold” rating in a report on Thursday, November 14th.
Read Our Latest Stock Analysis on Limbach
About Limbach
Limbach Holdings, Inc operates as a building systems solution company in the United States. It operates through two segments, General Contractor Relationships and Owner Direct Relationships. The company engages in the construction and renovation projects that involve primarily include mechanical, plumbing, and electrical services.
Featured Stories
- Five stocks we like better than Limbach
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Best Stocks Under $10.00
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How to Invest in Insurance Companies: A Guide
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding LMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Limbach Holdings, Inc. (NASDAQ:LMB – Free Report).
Receive News & Ratings for Limbach Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Limbach and related companies with MarketBeat.com's FREE daily email newsletter.